510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0308-2016Class II

DrugSmart 11 Test Cup, Item No. 61127D; DrugSmart 12 Test Cup (Multi & BUP), Item No. 61210D; DrugSmart 9...

Ameditech, Inc. / initiated 2015-10-20 / Terminated / root cause: manufacturing process

Ameditech Inc began a recall of DrugSmart 11 Test Cup, Item No. 61127D; DrugSmart 12 Test Cup (Multi & BUP), Item No. 61210D; DrugSmart 9 Test Cup (BUP), Item No. 60960D; DrugSmart Cup 10... on . FDA classified it as Class II and gives the reason as "Ameditech is recalling drug abuse tests because they have shown reduced reactivity". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0308-2016
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Ameditech, Inc.
Product
DrugSmart 11 Test Cup, Item No. 61127D; DrugSmart 12 Test Cup (Multi & BUP), Item No. 61210D; DrugSmart 9 Test Cup (BUP), Item No. 60960D; DrugSmart Cup 10, Item No. 61093D-3C These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.
Product code
JXM Enzyme Immunoassay, Benzodiazepine
Reason for recall
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
Ameditech Inc. sent an Urgent Medical Device Recall Letter to al affected customers on October 20, 2015, to inform them that Ameditech is recalling affected lots of Ameditech's Drugs of Abuse Tests because they have shown reduced reactivity for up to three of the nineteen Benzodiazepine (BZO) compounds. The letter informs customers of the actions to be taken. Customers were instructed to complete and return the customer verification form to (858) 677-0243 or scan and email to [email protected]. For questions regarding this recall call 858-535-1968.
Quantity in commerce
1220 units
Distribution
Worldwide Distribution - US (nationwide) and Internationally to Australia.
Product codes and lots
140770 142294 151050 151527 142527 140998 142526 150596 151122 151196

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0308-2016
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0298-2016Class IITerminatedVoluntary: Firm initiated
Z-0299-2016Class IITerminatedVoluntary: Firm initiated
Z-0300-2016Class IITerminatedVoluntary: Firm initiated
Z-0301-2016Class IITerminatedVoluntary: Firm initiated
Z-0302-2016Class IITerminatedVoluntary: Firm initiated
Z-0303-2016Class IITerminatedVoluntary: Firm initiated
Z-0304-2016Class IITerminatedVoluntary: Firm initiated
Z-0305-2016Class IITerminatedVoluntary: Firm initiated
Z-0306-2016Class IITerminatedVoluntary: Firm initiated
Z-0307-2016Class IITerminatedVoluntary: Firm initiated
Z-0308-2016Class IITerminatedVoluntary: Firm initiated
Z-0309-2016Class IITerminatedVoluntary: Firm initiated
Z-0310-2016Class IITerminatedVoluntary: Firm initiated
Z-0311-2016Class IITerminatedVoluntary: Firm initiated
Z-0312-2016Class IITerminatedVoluntary: Firm initiated
Z-0313-2016Class IITerminatedVoluntary: Firm initiated
Z-0314-2016Class IITerminatedVoluntary: Firm initiated
Z-0315-2016Class IITerminatedVoluntary: Firm initiated
Z-0316-2016Class IITerminatedVoluntary: Firm initiated
Z-0317-2016Class IITerminatedVoluntary: Firm initiated